Christopher C. Chapman JR

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Christopher Chapman, Jr., MD
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher C. Chapman JR:

Company Role Class Num Shares Value Price $ Report Date Ownership
Telomir Pharmaceuticals, Inc. CEO & Chairman, Director Common Stock 975,610 $6,048,782 $6.20 08 Feb 2024 Direct
MIRA PHARMACEUTICALS, INC. Executive Chairman, Director Common Stock 200,000 $310,820 $1.55 02 Aug 2023 Direct
MyMD Pharmaceuticals, Inc. President, Chief Med. Officer, Director Employee Stock Option (Right to Buy) 300,000 07 Jun 2023 Direct
MIRA PHARMACEUTICALS, INC. Executive Chairman, Director Stock Options 50,000 17 Aug 2023 Direct

Insider Reports Filed by Christopher C. Chapman JR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TELO Telomir Pharmaceuticals, Inc. 08 Feb 2024 0 $0 3 CEO & Chairman, Director 08 Feb 2024, 17:39
MIRA MIRA PHARMACEUTICALS, INC. 17 Aug 2023 1 $0 4 Executive Chairman, Director 21 Aug 2023, 19:00
MIRA MIRA PHARMACEUTICALS, INC. 02 Aug 2023 0 $0 3 Executive Chairman, Director 02 Aug 2023, 17:52
TNFA MyMD Pharmaceuticals, Inc. 07 Jun 2023 1 $0 4 President, Chief Med. Officer, Director 09 Jun 2023, 18:00
TNFA MyMD Pharmaceuticals, Inc. 04 Apr 2023 1 $0 4 President, Chief Med. Officer, Director 05 Apr 2023, 16:28
TNFA MyMD Pharmaceuticals, Inc. 14 Oct 2021 1 $0 4 President, Chief Med. Officer, Director 15 Oct 2021, 17:20